Partnering

Pantarhei’s objective is to develop and out-license patent protected concepts with clinically proven feasibility and safety (phase II) to pharmaceutical companies for final clinical development (phase III) and commercialisation.

For detailed information, please contact:

Olav Andriesse, LL.M MBA or Yvette Zimmerman, PhD

phone: + 31 (0)30 69 85 020
e-mail:  info@pantarheibio.com